Current Drug Metabolism
Volume 20, 14 Issues, 2019
ISSN: 1875-5453 (Online)
ISSN: 1389-2002 (Print)
This journal supports open access
ISSN: 1875-5453 (Online)
ISSN: 1389-2002 (Print)
This journal supports open access
Ranking and Category
-
200th of 298 in
Biochemistry & Molecular Biology
-
158th of 267 in
Pharmacology & Pharmacy
Contents
Current Drug Metabolism, Volume 20 - Number 4
Biography Open Access
Clinical Trial
Metabolism of the Dual Orexin Receptor Antagonist ACT-541468, Based on Microtracer/ Accelerator Mass Spectrometry
, 20(4): 254 - 265Clemens Muehlan*, Hartmut Fischer, Dieter Zimmer, Hamed Aissaoui, Julien Grimont, Christoph Boss, Marie Croft, Joop van Gerven, Stephan Krähenbühl and Jasper Dingemanse
DOI: 10.2174/1389200220666190206141814
Metabolism of the Dual Orexin Receptor Antagonist ACT-541468, Based on Microtracer/ Accelerator Mass Spectrometry
Systemic Review Article Open Access
Effects of CYP2C8 and SLCO1B1 Genetic Polymorphisms on Repaglinide Pharmacokinetics: A Systematic Review and Meta-Analysis
, 20(4): 266 - 274Shuang Zhou, Qian Xiang, Guangyan Mu, Lingyue Ma, Shuqing Chen, Qiufen Xie, Zhuo Zhang and Yimin Cui*
DOI: 10.2174/1389200220666190111114146
Effects of CYP2C8 and SLCO1B1 Genetic Polymorphisms on Repaglinide Pharmacokinetics: A Systematic Review and Meta-Analysis
Review Article
Herb-Drug Interactions and Hepatotoxicity
, 20(4): 275 - 282Mohammad K. Parvez* and Vikas Rishi
DOI: 10.2174/1389200220666190325141422
Herb-Drug Interactions and Hepatotoxicity
Review Article
Recent Findings on Nanotechnology-based Therapeutic Strategies Against Hepatocellular Carcinoma
, 20(4): 283 - 291Hany A. Abdel Samie*, Mohd Saeed, Syed Mohd Faisal, Mohd Adnan Kausar and Mohammad A. Kamal*
DOI: 10.2174/1389200220666190308134351
Recent Findings on Nanotechnology-based Therapeutic Strategies Against Hepatocellular Carcinoma
Review Article
A Metabonomics Approach to Drug Toxicology in Liver Disease and its Application in Traditional Chinese Medicine
, 20(4): 292 - 300Guangyue Su , Haifeng Wang*, Jiao Bai , Gang Chen and Yuehu Pei
DOI: 10.2174/1389200220666181231124439
A Metabonomics Approach to Drug Toxicology in Liver Disease and its Application in Traditional Chinese Medicine
Review Article
PI3K/Akt-Nrf2 and Anti-Inflammation Effect of Macrolides in Chronic Obstructive Pulmonary Disease
, 20(4): 301 - 304Xuejiao Sun, Lin Chen and Zhiyi He*
DOI: 10.2174/1389200220666190227224748
PI3K/Akt-Nrf2 and Anti-Inflammation Effect of Macrolides in Chronic Obstructive Pulmonary Disease
Review Article
Genitourinary Tumors: Update on Molecular Biomarkers for Diagnosis, Prognosis and Prediction of Response to Therapy
, 20(4): 305 - 312Alessia Cimadamore, Marina Scarpelli, Matteo Santoni, Francesco Massari, Francesca Tartari, Roy Cerqueti, Antonio Lopez-Beltran, Liang Cheng and Rodolfo Montironi*
DOI: 10.2174/1389200220666190225124352
Genitourinary Tumors: Update on Molecular Biomarkers for Diagnosis, Prognosis and Prediction of Response to Therapy
Review Article
Clinical Implications of Methotrexate Pharmacogenetics in Childhood Acute Lymphoblastic Leukaemia
, 20(4): 313 - 330Guillermo Gervasini* and Sonia Mota-Zamorano
DOI: 10.2174/1389200220666190130161758
Clinical Implications of Methotrexate Pharmacogenetics in Childhood Acute Lymphoblastic Leukaemia
  |
Editor-in-Chief
Michael Sinz
Bristol Myers Squibb
Princeton, NJ
USA
Biography
View Full Editorial Board
Bristol Myers Squibb
Princeton, NJ
USA
Biography
Biography of Michael Sinz
Michael W. Sinz, Ph.D. is Director of Metabolism and Pharmacokinetics at Bristol Myers Squibb where he manages ADmezME lead optimization in drug discovery. Dr. Sinz previously held the position of Section Director-Pharmacokinetics and Drug Metabolism for Parke-Davis/Pfizer. He received B.S. degrees in Chemistry (ACS) and Biology from the University of Wisconsin-Eau Claire and a Ph.D. in Pharmacognosy/Medicinal Chemistry from the University of Minnesota (2001). He is editor in chief of Current Drug Metabolism and associate editor of Drug Metabolism Letters. Dr. Sinz’s resume includes an extensive number of peer reviewed publications, book chapters, and external presentations both locally and internationally.
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Drug Metabolism was launched in 2000. Dr. Michael Sinz serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net